logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Jeffrey L Browning

This inventor holds 43 USPTO granted patents and 8 published patent applications and 9 EPO patents, primarily in Immunological Therapies. Top assignees: Biogen Idec Ma Inc., Biogen, Incorporated, The Faculty of Medicine of the University of Geneva. Active years: 1994-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey L Browning. Retrieved from https://idiyas.com/inventor/jeffrey-l-browning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 43 

% Patents Active = 55.8

 

Average Co-Inventor Count = 2.9

ph-index = 15

Forward Citations = 541(Granted Patents)


Location History:

  • Cambridge, MA (US) (1994 - 2010)
  • Brookline, MA (US) (1997 - 2019)

Company Filing History:

goldMedal30 out of 216 
 
Biogen Idec Ma Inc.
 patents
silverMedal10 out of 130 
 
Biogen, Incorporated
 patents
bronzeMedal5 out of 5 
 
The Faculty of Medicine of the University of Geneva
 patents
4. 4 out of 16,058 
 
University of California
 patents
5. 3 out of 1,732 
 
New York University
 patents
6. 2 out of 269 
 
Biogen Ma Inc.
 patents
7. 1 out of 7 
 
Apoxis S.a.
 patents
8. 1 out of 1,030 
 
Emory University
 patents
9. 1 out of 1,331 
 
The University of North Carolina at Chapel Hill
 patents
10. 1 out of 3 
 
Topotarget Switzerland Sa
 patents
11. 1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
BCMA Polypeptide
Lymphotoxin Receptors
Tumor Necrosis Factor
Autoimmune Diseases
Immunological Diseases
Therapeutic Agents
B-Cell Maturation
Anti-Tumor Agents
Receptor Agonists
Demyelinating Disorders
Neurite Outgrowth
Follicular Lymphomas
43 patents (USPTO):Explore Patents
1. 10494416 - Methods of modulating immune responses using BCMA polypeptide (2019-12-03),
2. 9650430 - Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) (2017-05-16),
3. 8828669 - Methods of screening for a compound that inhibits the interaction between BAFF and BCMA (2014-09-09),
4. 8709759 - Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins (2014-04-29),
5. 8455445 - Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders (2013-06-04),
6. 8338376 - Compositions comprising variant LT-B-R-IG fusion proteins (2012-12-25),
7. 8287874 - Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases (2012-10-16),
8. 8283138 - Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins (2012-10-09),
9. 8142779 - Treatment of follicular lymphomas using inhibitors of the LT pathway (2012-03-27),
10. 8067375 - Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor (2011-11-29),
11. 7951371 - Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling (2011-05-31),
12. 7947271 - Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents (2011-05-24),
13. 7846438 - Methods of promoting neurite outgrowth with soluble TAJ polypeptides (2010-12-07),
14. 7799902 - Receptor coupling agents and compositions thereof (2010-09-21),
15. 7744891 - Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases (2010-06-29),

Title: The Innovative Mind of Jeffrey L Browning

Introduction: Jeffrey L Browning, a talented inventor based in Cambridge, MA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Jeffrey L Browning holds several patents in various technological fields, including artificial intelligence, renewable energy, and biotechnology. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a background in computer science and engineering, Jeffrey has worked for leading tech companies in Silicon Valley before establishing his own startup in Cambridge. Throughout his career, he has been recognized for his innovative thinking and problem-solving skills.

Collaborations: Jeffrey L Browning has collaborated with top researchers from renowned universities such as MIT and Harvard, as well as leading tech companies like Google and IBM. These collaborations have led to the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: Jeffrey L Browning continues to push the boundaries of innovation with his passion for creating solutions that address complex challenges in the tech industry. His dedication to advancing technology and improving the world around him makes him a true visionary in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…